to Content
Header Image

Special Event 3: Medical Schools in the International Context – Challenges and Opportunities

-
Hotel Alpbacherhof
Breakout /
in englischer Sprache

Based on the Austrian University Act 2002 and its implementation, the three Medical Faculties became independent Medical Universities with full legal capacity as of January 2004. Consequently, the three new Medical Universities are faced with a broad spectrum of opportunities as well as challenges.
The forum will provide a platform for the exchange of experiences after the first period of independence and will foster discussions towards the positioning of Medical Universities in the European Research and Higher Education Area as well as in the wider international context.
International speakers from a selected range of academic and industrial organisations will describe their specific experiences and expectations.

President of the Hannover Medical School (MHH)
Dean of Research, Karolinska Institutet
Executive Vice President, Vienna School of Clinical Research, Vienna
Dean of University College of Nursing Studies University of Maribor
Head of the Office for Integration with European Union, Medical University of Lodz
Associate Director, Cardiovascular Surgery and Transplant Research, Texas Heart Institute Houston, Texas Clinical Associate Professor of Surgery (Thoracic and Cardiovascular) Department of Surgery, University of Texas Medical School Houston, Texas
Rektor, Medizinische Universität Graz
Chief Executive Officer, Infineon Technologies Austria AG, Villach Chair
Deputy Director General Chair
Head of the Office of the Vice Rector for Research Management & International Cooperation, Medical University of Graz Coordination

Dr. Dieter BITTER-SUERMANN

President of the Hannover Medical School (MHH)

1959-1965 Medicine, Würzburg, Wien, Göttingen
1959-1974 Research Fellow in Med. Microbiology at Johannes-Gutenberg-University, Mainz
1968-2003 Research interests: Innate Immune System, Complement System, Anaphylatoxic Peptides, Bacterial factors of pathogenicity, Capsule antigens
since 1974 Associate Professor for Medical Microbiology at the Institute of Medical Microbiology, Mainz
1987-2003 Chair and Director of the Institute of Medical Microbiology at MHH
1994-1998 Medical Director of the MHH
since 2004 President of MHH

MD, PhD Jan CARLSTEDT-DUKE

Dean of Research, Karolinska Institutet

1979 PhD Karolinska Institutet (KI)
1981 MD KI
1983 Docent in medical chemistry, KI
1984 Licensed physician
1984-1985 Research fellowship, Swedish Cancer Society
1984-1997 Pediatric endocrinologist, Huddinge University Hospital
1985 Associate professor of molecular endocrinology, KI
1989-1995 Senior research scientist, Swedish Medical Research Council
1996 Professor of molecular endocrinology, KI
1999 Vice dean of research, KI
2001 Dean of research, KI

Dr. Heinrich KLECH

Executive Vice President, Vienna School of Clinical Research, Vienna

1967-1974 Medizinstudium, Universität Wien
1980 Facharzt für Lungenerkrankungen
1980-1984 Lehraufenthalte, US (Mayo Clinic, Rochester, Mont Sinai Hospital, N.Y.)
1980-1990 Spitalsoberarzt, 2.Med.Wilhelminenspital, Leitung: Prof.Dr.F.Kummer
1984-1993 Kammerrat, Wr. Ärztekammer
seit 1985 Referate für Ärzte in der Pharmaindustrie, Wr. Ärztekammer
Leiter, Referat für Pharmaangelegenheiten der Wr. Ärztekammer
1986-1999 Referent, ärztliche Fortbildung der Österr. Ärztekammer
seit 1987 Mitglied, Executive Committee on World Association of Sarcoidosis
Wissenschaftl Beirat, "Atemwegs- und Lungenerkrankungen"
1987-1999 Vorsitzender, Europ.BAL Task Group
1989 Facharzt, Innere Medizin
Habilitation, Dozent f.Innere Medizin, Universität Wien
1990-2000 Wissenschaftl. Leiter, Ludwig Boltzmann Institut für bronchoalveoläre Lavage, Wien
1990 Wahl zum Vorsitzenden, Scientific Group BAL, ERS (European Respiratory Society )
1990-1993 Mitglied, Scientific Council, ERS
1990-1994 Mitglied, International Advisory Committee, American Thoracic Society
1990-2002 Kongreßleiter, "Ärztewoche im Gasteinertal"
1992-1997 Associate Editor, "European Respiratory Journal"
1992-2000 Initiator, Generalsekretär (1989), Vorsitzender (1998) ,Initiative "Ärzte gegen Raucherschäden", a.o. Professor, Universität Wien
seit 1991 Direktor, Forschung und Entwicklung, Area Medical Center, Wien, Eli Lilly, Zentral/Ost Europa, Zentral Asien, Mittlerer Osten, Afrika
seit 1999 Finanzvorstand, Akademie der Ärzte
seit 2000 Vicepresident, Vienna School of Clinical Research, Wien
seit 2008 CEO, Executive Vice President, Vienna School of Clinical Research, Wien

Dr. Dusanka MICETIC-TURK

Dean of University College of Nursing Studies University of Maribor

1965-1970 Graduate Course: Faculty of Medicine, University of Rijeka, Croatia
since 1971 Employment: Maribor Teaching Hospital
1974-1975 Postgraduate Course: Protection of Mother and Child, Zagreb, Croatia
1976 Specialization in Paediatrics, Clinical Hospital Ljubljana
1980 Master Degree: Faculty of Medicine, University of Zagreb, Croatia
1987 PhD: Faculty of Medicine, University of Ljubljana, Slovenia
1989 Assistant Professor in Paediatrics at the University of Ljubljana
Professor at the University of Ljubljana
since 1997 Dean of University College of Nursing Studies University of Maribor
2001 Full Professor at the University of Maribor

MD Ph.D. Jacek MICHALAK

Head of the Office for Integration with European Union, Medical University of Lodz

1975-1986 Research worker in Department of Histology and Embryology, Medical Academy of Lodz
1986-1991 Pediatrician in an outpatient clinic
1991-1993 Deputy Director of the Department of Public Health (City Doctor)
1993- 2003 Assist. Prof Nofer Instutitute of Occupational Medicine, Lodz, Poland, Department of Health Care Organization
 Since 1999 Senior Medical Advisor for Poland, UNILEVER (part time)
 Since 2003 Head of the Office for Integration with European Union, Medical University of Lodz, Poland

M.D. Branislav RADOVANCEVIC

Associate Director, Cardiovascular Surgery and Transplant Research, Texas Heart Institute Houston, Texas Clinical Associate Professor of Surgery (Thoracic and Cardiovascular) Department of Surgery, University of Texas Medical School Houston, Texas

1978 University of Belgrade, Medical Degree
1979-1981 City Hospital, First Surgical Clinic-University of Belgrade
1981-1984 Clinical Hospital, Dr. D. Misovic, Belgrade Department of Cardiovascular Surgery
1984-1991 Transplantation (Cardiac and Renal) Circulatory Support, Basic and Clinical Research, Texas Heart Institute, Houston, Texas
since 1993 Clinical Associate Professor of Surgery (Thoracic and Cardiovascular) Department of Surgery, University of Texas Medical School Houston, Texas
since 1998 Associate Director, Cardiovascular Surgery and Transplant Research, Texas Heart Institute Houston, Texas

DDr. Gerhard Franz WALTER

Rektor, Medizinische Universität Graz

1975 Dr.med.univ.
1976 Dr.phil
1975-1977 Universität Graz
1977-1978 Freie Universität Berlin
1978-1980 Université Catholique de Louvain
1980-1985 Universität Graz
1985-2003 Professor für Neuropathologie - Med. Hochschule Hannover
2003 Rektor der Medizinischen Universität Graz

DI Dr. MBA Sabine HERLITSCHKA

Chief Executive Officer, Infineon Technologies Austria AG, Villach

1990 Forscherin, Dissertantin und Post Doctoral Research bei Immuno AG
1996 Referatsleiterin und stv. Direktorin des BIT-Büros für Internationale Forschungs- und Technologiekooperation
2003 Praktika bei der U.S. National Science Foundation, American Association for the Advancement of Science und Kooperation mit dem Wissenschaftsberater im U.S. Department of State, Washington DC
Vizerektorin für Forschungsmanagement und Internationale Kooperationen an der Medizinischen Universität Graz
2006 Bereichsleiterin Europäische und Internationale Programme der FFG - Österreichische Forschungsförderungsgesellschaft, Wien
2010 Fulbright Scholar an der George Washington University und Johns Hopkins University/School of Advanced International Studies, Washington DC
2011 Vorstandsmitglied der Infineon Technologies Austria AG
seit 2012 Vorstand für Technik und Innovation der Infineon Technologies Austria AG
seit 2014 Vorstandsvorsitzende der Infineon Technologies Austria AG

Mag. Markus PASTERK

Deputy Director General

1985 - 1986 Military Service, current rank Captain
1986 - 1993 Study of Molecular Genetics, University of Vienna, M.Sc. 1994
1993 - 1995 Institute Manager, Institute of Microbiology and Genetics, University of Vienna
1996 - 2001 Scientifc Officer at the bm:bwk
since 2001 Director for Research Policy and Life Sciences, bm:bwk
since 2002 Deputy Director General, bm:bwk

Mag. Dr. Carolin AUER

Head of the Office of the Vice Rector for Research Management & International Cooperation, Medical University of Graz

1989-1996 English/American Studies, Italian Studies (University of Graz)
1993-1994 Graduate Studies in Comparative Literature / Teaching Assistantship (State University of New York at Binghamton)
1995 Research scholarship (John-F.-Kennedy-Institute, Free University Berlin)
1996-1999 Doctoral Studies in American Studies / Research & Teaching Assistantship (University of Graz)
1998 Visiting Scholar (City University of New York)
1999-2000 Lecturer (University of Graz) / Assistant to the Director (Graz Center for Peace and Development)
2000-2003 Head of the Office of Research Service (University of Graz)
since 2003 Head of the Office of the Vice Rector for Research Management & International Cooperation, Medical University of Graz)

Technology Symposium

show timetable
Genre : all

26.08.2004

08:00 - 09:30Technology brunch sponsored by Tiroler ZukunftsstiftungSocial
11:00 - 12:00Welcome receptionPlenary
12:00 - 13:30Where Do We Come From?Plenary
14:00 - 16:30TomorrowPlenary
18:00 - 18:30ResponsibilityPlenary
18:30 - 19:30First-world know-how, third-world solutions: a comparison of outcomePlenary
19:30 - 21:30Evening reception, sponsored by Alcatel AustriaSocial

27.08.2004

07:00 - 13:30Working Group 01: Technological Potentials for Achieving Climate Protection Goals with or without Kyoto-Protocol RatificationBreakout
07:00 - 13:30Working Group 02: Low-Carbon Energy SupplyBreakout
07:00 - 13:30Working Group 03: New Forms of Organization: Best Practice-Methods of Change Management – the Art of Managing ChangeBreakout
07:00 - 13:30Working Group 04: Crossing Borders: Overcoming Barriers – Bridging Disciplines – Rethinking CulturesBreakout
07:00 - 13:30Working Group 05: Space Policy: A New Strategic Challenge for EuropeBreakout
07:00 - 13:30Working Group 06: From Vienna to Lisbon? – Challenges for Innovation Policy on EU and National Levels in the Light of the New EU Action Plan for Innovation and the Austrian Efforts for an Innovation StrategyBreakout
07:00 - 13:30Working Group 07: Man and Machine – Interactions in the Ambient Intelligent SocietyBreakout
07:00 - 13:30Working Group 08: Security and IdentificationBreakout
07:00 - 13:30Working Group 09: Lost in Technology? – Women Careers in Research and TechnologyBreakout
07:00 - 13:30Working Group 10: Challenges of Regenerative MedicineBreakout
07:00 - 13:30Working Group 11: Telematics in Transport – Opportunities for a Mobile SocietyBreakout
07:00 - 13:30Working Group 12: MyLifeBits – Digital Immortality and its LimitsBreakout
07:00 - 13:30Special Event 1: Cooperation in South East Europe – Programs, Projects, InitiativesBreakout
07:00 - 13:30Special Event 2: The Politics of Technology: A Primer on Innovative Developments that Governments Should Embrace to Kick-Start GNPBreakout
07:00 - 13:30Special Event 3: Medical Schools in the International Context – Challenges and OpportunitiesBreakout
14:00 - 15:00Science Policy: the major players in science and research – competition and cooperation, conditions for success “Precompetitive Research”Plenary
15:00 - 16:00Science Policy: the major players in science and research – competition and cooperation, conditions for success “Competitive Research”Plenary
18:00 - 20:00Information transfer and processingPlenary

28.08.2004

07:00 - 07:45The Ig Nobel PrizesPlenary
07:45 - 08:00Alpbach 2004 – My personal resuméePlenary
08:00 - 08:30Alpbach 2004 – resumée Junior AlpbachPlenary
09:00 - 10:30Seeing Beyond the Light: Technology and Patient s Benefit on the Example of Molecular ImagingPlenary
10:30 - 11:15Closing statementPlenary
11:30 - 12:00Farewell reception sponsored by Microsoft AustriaSocial